Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Accenture
ACN
$106B
| $64.2M | 0.08% |
566,457
+197,938
| +54% | +$23M |
|
202
Phillips 66
PSX
$82.9B
| $64.1M | 0.08% |
808,212
+565,660
| +233% | +$46.2M |
|
203
CALL
VanEck Junior Gold Miners ETF
GDXJ
$6.86B
| $63.8M | 0.08% |
1,497,700
+352,400
| +31% | +$12.7M |
|
204
Broadcom
AVGO
$1.76T
| $63.7M | 0.08% |
4,100,950
-519,790
| -11% | -$7.92M |
|
205
HCA Healthcare
HCA
$90.6B
| $63.4M | 0.08% |
823,081
+148,758
| +22% | +$11.7M |
|
|
LNKD
206
DELISTED
LinkedIn Corporation
LNKD
| $63.1M | 0.08% |
333,251
+33,869
| +11% | +$4.69M |
|
207
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $62.7M | 0.08% |
1,779,047
+1,619,347
| +1,014% | +$55.3M |
|
208
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
| $62.7M | 0.08% |
451,065
-1,334,891
| -75% | -$176M |
|
|
AGN
209
DELISTED
Allergan plc
AGN
| $62.3M | 0.08% |
269,530
-136,359
| -34% | -$31.4M |
|
210
Union Pacific
UNP
$174B
| $62M | 0.08% |
710,429
-113,546
| -14% | -$9.6M |
|
211
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
| $61.6M | 0.08% |
859,416
-809,581
| -49% | -$57M |
|
|
AGN
212
CALL
DELISTED
Allergan plc
AGN
| $61.3M | 0.08% |
265,200
+72,300
| +37% | +$16.7M |
|
213
MetLife
MET
$62.4B
| $61M | 0.08% |
1,717,351
+138,201
| +9% | +$5.39M |
|
214
CALL
Teva Pharmaceuticals
TEVA
$40.4B
| $60.2M | 0.08% |
1,198,900
+934,000
| +353% | +$49.7M |
|
215
EOG Resources
EOG
$77.7B
| $60.1M | 0.08% |
720,433
+41,523
| +6% | +$3.33M |
|
216
Ecolab
ECL
$79.8B
| $59.5M | 0.08% |
501,302
+121,156
| +32% | +$14.1M |
|
217
Paychex
PAYX
$43.4B
| $59.3M | 0.08% |
996,369
+453,558
| +84% | +$24.3M |
|
218
PUT
Johnson & Johnson
JNJ
$640B
| $59.1M | 0.08% |
487,000
-248,300
| -34% | -$28.2M |
|
219
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
| $58.8M | 0.08% |
422,462
+73,591
| +21% | +$10.1M |
|
220
PUT
PepsiCo
PEP
$196B
| $58.7M | 0.08% |
554,300
+112,100
| +25% | +$11.6M |
|
221
Cognizant
CTSH
$26.5B
| $58.5M | 0.08% |
1,021,868
+394,958
| +63% | +$23.9M |
|
|
ETP
222
DELISTED
Energy Transfer Partners L.p.
ETP
| $58.3M | 0.08% |
1,531,417
+2,474
| +0.2% | +$88.6K |
|
223
eBay
EBAY
$51.2B
| $58.1M | 0.08% |
2,482,090
-215,621
| -8% | -$5.2M |
|
224
Danaher
DHR
$138B
| $57.8M | 0.08% |
851,754
+167,662
| +25% | +$11M |
|
|
RAI
225
DELISTED
Reynolds American Inc
RAI
| $57.8M | 0.08% |
1,071,310
+40,823
| +4% | +$2.05M |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.